Clinicopathological features of breast angiosarcoma
Background Breast angiosarcomas are rare neoplasm. Due to its rarity, our therapeutic strategy is extremely limited. Therefore, we investigated the clinicopathologic features and examined the treatment for angiosarcoma compared with some literatures. Methods We conducted a retrospective chart and sl...
Gespeichert in:
Veröffentlicht in: | Breast cancer (Tokyo, Japan) Japan), 2016-09, Vol.23 (5), p.718-723 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 723 |
---|---|
container_issue | 5 |
container_start_page | 718 |
container_title | Breast cancer (Tokyo, Japan) |
container_volume | 23 |
creator | Masai, Kyohei Kinoshita, Takayuki Jimbo, Kenjiro Asaga, Sota Hojo, Takashi |
description | Background
Breast angiosarcomas are rare neoplasm. Due to its rarity, our therapeutic strategy is extremely limited. Therefore, we investigated the clinicopathologic features and examined the treatment for angiosarcoma compared with some literatures.
Methods
We conducted a retrospective chart and slide review of all patients in our division seen from 1997 to 2012 with a diagnosis of primary or secondary breast angiosarcoma at the National Cancer Center Hospital (Tokyo, Japan).
Results
Nine patients were diagnosed with breast angiosarcoma (six primary and three secondary cases). The median age of patients with primary angiosarcoma was 39 years (range 27–65 years). The median tumor size was 6.78 cm (range 3.0–8.8 cm). In the primary tumor, 4 patients had total mastectomy and 2 had a breast conserving surgery. 3- and 5-year disease-free survival (DFS) of the patients with primary angiosarcoma was 20 and 0 %. 5-year surviving rate of primary angiosarcoma was 50 %. In all patients with secondary angiosarcoma, recurrence was observed in all cases. But one case obtained long-term survival in local control therapy.
Conclusions
Our study demonstrates breast angiosarcoma exhibits high recurrence rates. Tumor size and surgical margin may be important factor to obtain long-term survival. In this point of view, total mastectomy with adequate tumor margin with early detection is desired. In case of recurrence, if it is local, surgery may be potentially curative. |
doi_str_mv | 10.1007/s12282-015-0630-y |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1814676050</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A712277187</galeid><sourcerecordid>A712277187</sourcerecordid><originalsourceid>FETCH-LOGICAL-c501t-3219b23eb50b4cd4ddcbd289801f08e77ae972e57106c70c7836fcde84f2d0973</originalsourceid><addsrcrecordid>eNp9kU9LwzAYxoMoOqcfwIsMvHipvknaJDuO4T8YeNFzSNM3s6NtZtIe9u3N6BQEkRySN_k9D-F5CLmicEcB5H2kjCmWAS0yEByy3RGZUKUgyxnnx-nMc8iEEuqMnMe4Aci5BHFKzphgOU_ThPBlU3e19VvTf_jGr2trmplD0w8B48y7WRnQxH5munXtownWt-aCnDjTRLw87FPy_vjwtnzOVq9PL8vFKrMF0D7jjM5LxrEsoMxtlVeVLSum5gqoA4VSGpxLhoWkIKwEKxUXzlaocscqmEs-Jbej7zb4zwFjr9s6Wmwa06EfoqaK5kIKKCChNyO6Ng3qunO-D8bucb2QKSUpqdob3v1BpVVhmzLo0NXp_peAjgIbfIwBnd6GujVhpynofQV6rECnCvS-Ar1LmuvDr4eyxepH8Z15AtgIxPTUrTHojR9Cl5L8x_ULUZCPjQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1814676050</pqid></control><display><type>article</type><title>Clinicopathological features of breast angiosarcoma</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Masai, Kyohei ; Kinoshita, Takayuki ; Jimbo, Kenjiro ; Asaga, Sota ; Hojo, Takashi</creator><creatorcontrib>Masai, Kyohei ; Kinoshita, Takayuki ; Jimbo, Kenjiro ; Asaga, Sota ; Hojo, Takashi</creatorcontrib><description>Background
Breast angiosarcomas are rare neoplasm. Due to its rarity, our therapeutic strategy is extremely limited. Therefore, we investigated the clinicopathologic features and examined the treatment for angiosarcoma compared with some literatures.
Methods
We conducted a retrospective chart and slide review of all patients in our division seen from 1997 to 2012 with a diagnosis of primary or secondary breast angiosarcoma at the National Cancer Center Hospital (Tokyo, Japan).
Results
Nine patients were diagnosed with breast angiosarcoma (six primary and three secondary cases). The median age of patients with primary angiosarcoma was 39 years (range 27–65 years). The median tumor size was 6.78 cm (range 3.0–8.8 cm). In the primary tumor, 4 patients had total mastectomy and 2 had a breast conserving surgery. 3- and 5-year disease-free survival (DFS) of the patients with primary angiosarcoma was 20 and 0 %. 5-year surviving rate of primary angiosarcoma was 50 %. In all patients with secondary angiosarcoma, recurrence was observed in all cases. But one case obtained long-term survival in local control therapy.
Conclusions
Our study demonstrates breast angiosarcoma exhibits high recurrence rates. Tumor size and surgical margin may be important factor to obtain long-term survival. In this point of view, total mastectomy with adequate tumor margin with early detection is desired. In case of recurrence, if it is local, surgery may be potentially curative.</description><identifier>ISSN: 1340-6868</identifier><identifier>EISSN: 1880-4233</identifier><identifier>DOI: 10.1007/s12282-015-0630-y</identifier><identifier>PMID: 26243043</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Adult ; Aged ; Angiosarcoma ; Biopsy, Large-Core Needle ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Breast Neoplasms - therapy ; Cancer Research ; Care and treatment ; Disease-Free Survival ; Female ; Health aspects ; Hemangiosarcoma - mortality ; Hemangiosarcoma - pathology ; Hemangiosarcoma - therapy ; Humans ; Lumpectomy ; Lymphangiosarcoma - pathology ; Mastectomy, Segmental - mortality ; Mastectomy, Simple - mortality ; Medicine ; Medicine & Public Health ; Middle Aged ; Neoplasm Recurrence, Local - pathology ; Oncology ; Original Article ; Retrospective Studies ; Surgery ; Surgical Oncology ; Survival Rate</subject><ispartof>Breast cancer (Tokyo, Japan), 2016-09, Vol.23 (5), p.718-723</ispartof><rights>The Japanese Breast Cancer Society 2015</rights><rights>COPYRIGHT 2016 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c501t-3219b23eb50b4cd4ddcbd289801f08e77ae972e57106c70c7836fcde84f2d0973</citedby><cites>FETCH-LOGICAL-c501t-3219b23eb50b4cd4ddcbd289801f08e77ae972e57106c70c7836fcde84f2d0973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12282-015-0630-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12282-015-0630-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26243043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Masai, Kyohei</creatorcontrib><creatorcontrib>Kinoshita, Takayuki</creatorcontrib><creatorcontrib>Jimbo, Kenjiro</creatorcontrib><creatorcontrib>Asaga, Sota</creatorcontrib><creatorcontrib>Hojo, Takashi</creatorcontrib><title>Clinicopathological features of breast angiosarcoma</title><title>Breast cancer (Tokyo, Japan)</title><addtitle>Breast Cancer</addtitle><addtitle>Breast Cancer</addtitle><description>Background
Breast angiosarcomas are rare neoplasm. Due to its rarity, our therapeutic strategy is extremely limited. Therefore, we investigated the clinicopathologic features and examined the treatment for angiosarcoma compared with some literatures.
Methods
We conducted a retrospective chart and slide review of all patients in our division seen from 1997 to 2012 with a diagnosis of primary or secondary breast angiosarcoma at the National Cancer Center Hospital (Tokyo, Japan).
Results
Nine patients were diagnosed with breast angiosarcoma (six primary and three secondary cases). The median age of patients with primary angiosarcoma was 39 years (range 27–65 years). The median tumor size was 6.78 cm (range 3.0–8.8 cm). In the primary tumor, 4 patients had total mastectomy and 2 had a breast conserving surgery. 3- and 5-year disease-free survival (DFS) of the patients with primary angiosarcoma was 20 and 0 %. 5-year surviving rate of primary angiosarcoma was 50 %. In all patients with secondary angiosarcoma, recurrence was observed in all cases. But one case obtained long-term survival in local control therapy.
Conclusions
Our study demonstrates breast angiosarcoma exhibits high recurrence rates. Tumor size and surgical margin may be important factor to obtain long-term survival. In this point of view, total mastectomy with adequate tumor margin with early detection is desired. In case of recurrence, if it is local, surgery may be potentially curative.</description><subject>Adult</subject><subject>Aged</subject><subject>Angiosarcoma</subject><subject>Biopsy, Large-Core Needle</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - therapy</subject><subject>Cancer Research</subject><subject>Care and treatment</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Health aspects</subject><subject>Hemangiosarcoma - mortality</subject><subject>Hemangiosarcoma - pathology</subject><subject>Hemangiosarcoma - therapy</subject><subject>Humans</subject><subject>Lumpectomy</subject><subject>Lymphangiosarcoma - pathology</subject><subject>Mastectomy, Segmental - mortality</subject><subject>Mastectomy, Simple - mortality</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival Rate</subject><issn>1340-6868</issn><issn>1880-4233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9LwzAYxoMoOqcfwIsMvHipvknaJDuO4T8YeNFzSNM3s6NtZtIe9u3N6BQEkRySN_k9D-F5CLmicEcB5H2kjCmWAS0yEByy3RGZUKUgyxnnx-nMc8iEEuqMnMe4Aci5BHFKzphgOU_ThPBlU3e19VvTf_jGr2trmplD0w8B48y7WRnQxH5munXtownWt-aCnDjTRLw87FPy_vjwtnzOVq9PL8vFKrMF0D7jjM5LxrEsoMxtlVeVLSum5gqoA4VSGpxLhoWkIKwEKxUXzlaocscqmEs-Jbej7zb4zwFjr9s6Wmwa06EfoqaK5kIKKCChNyO6Ng3qunO-D8bucb2QKSUpqdob3v1BpVVhmzLo0NXp_peAjgIbfIwBnd6GujVhpynofQV6rECnCvS-Ar1LmuvDr4eyxepH8Z15AtgIxPTUrTHojR9Cl5L8x_ULUZCPjQ</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Masai, Kyohei</creator><creator>Kinoshita, Takayuki</creator><creator>Jimbo, Kenjiro</creator><creator>Asaga, Sota</creator><creator>Hojo, Takashi</creator><general>Springer Japan</general><general>Springer</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160901</creationdate><title>Clinicopathological features of breast angiosarcoma</title><author>Masai, Kyohei ; Kinoshita, Takayuki ; Jimbo, Kenjiro ; Asaga, Sota ; Hojo, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c501t-3219b23eb50b4cd4ddcbd289801f08e77ae972e57106c70c7836fcde84f2d0973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Angiosarcoma</topic><topic>Biopsy, Large-Core Needle</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - therapy</topic><topic>Cancer Research</topic><topic>Care and treatment</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Health aspects</topic><topic>Hemangiosarcoma - mortality</topic><topic>Hemangiosarcoma - pathology</topic><topic>Hemangiosarcoma - therapy</topic><topic>Humans</topic><topic>Lumpectomy</topic><topic>Lymphangiosarcoma - pathology</topic><topic>Mastectomy, Segmental - mortality</topic><topic>Mastectomy, Simple - mortality</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Masai, Kyohei</creatorcontrib><creatorcontrib>Kinoshita, Takayuki</creatorcontrib><creatorcontrib>Jimbo, Kenjiro</creatorcontrib><creatorcontrib>Asaga, Sota</creatorcontrib><creatorcontrib>Hojo, Takashi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer (Tokyo, Japan)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Masai, Kyohei</au><au>Kinoshita, Takayuki</au><au>Jimbo, Kenjiro</au><au>Asaga, Sota</au><au>Hojo, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinicopathological features of breast angiosarcoma</atitle><jtitle>Breast cancer (Tokyo, Japan)</jtitle><stitle>Breast Cancer</stitle><addtitle>Breast Cancer</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>23</volume><issue>5</issue><spage>718</spage><epage>723</epage><pages>718-723</pages><issn>1340-6868</issn><eissn>1880-4233</eissn><abstract>Background
Breast angiosarcomas are rare neoplasm. Due to its rarity, our therapeutic strategy is extremely limited. Therefore, we investigated the clinicopathologic features and examined the treatment for angiosarcoma compared with some literatures.
Methods
We conducted a retrospective chart and slide review of all patients in our division seen from 1997 to 2012 with a diagnosis of primary or secondary breast angiosarcoma at the National Cancer Center Hospital (Tokyo, Japan).
Results
Nine patients were diagnosed with breast angiosarcoma (six primary and three secondary cases). The median age of patients with primary angiosarcoma was 39 years (range 27–65 years). The median tumor size was 6.78 cm (range 3.0–8.8 cm). In the primary tumor, 4 patients had total mastectomy and 2 had a breast conserving surgery. 3- and 5-year disease-free survival (DFS) of the patients with primary angiosarcoma was 20 and 0 %. 5-year surviving rate of primary angiosarcoma was 50 %. In all patients with secondary angiosarcoma, recurrence was observed in all cases. But one case obtained long-term survival in local control therapy.
Conclusions
Our study demonstrates breast angiosarcoma exhibits high recurrence rates. Tumor size and surgical margin may be important factor to obtain long-term survival. In this point of view, total mastectomy with adequate tumor margin with early detection is desired. In case of recurrence, if it is local, surgery may be potentially curative.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>26243043</pmid><doi>10.1007/s12282-015-0630-y</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1340-6868 |
ispartof | Breast cancer (Tokyo, Japan), 2016-09, Vol.23 (5), p.718-723 |
issn | 1340-6868 1880-4233 |
language | eng |
recordid | cdi_proquest_miscellaneous_1814676050 |
source | MEDLINE; SpringerNature Journals |
subjects | Adult Aged Angiosarcoma Biopsy, Large-Core Needle Breast Neoplasms - mortality Breast Neoplasms - pathology Breast Neoplasms - therapy Cancer Research Care and treatment Disease-Free Survival Female Health aspects Hemangiosarcoma - mortality Hemangiosarcoma - pathology Hemangiosarcoma - therapy Humans Lumpectomy Lymphangiosarcoma - pathology Mastectomy, Segmental - mortality Mastectomy, Simple - mortality Medicine Medicine & Public Health Middle Aged Neoplasm Recurrence, Local - pathology Oncology Original Article Retrospective Studies Surgery Surgical Oncology Survival Rate |
title | Clinicopathological features of breast angiosarcoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T20%3A11%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinicopathological%20features%20of%20breast%20angiosarcoma&rft.jtitle=Breast%20cancer%20(Tokyo,%20Japan)&rft.au=Masai,%20Kyohei&rft.date=2016-09-01&rft.volume=23&rft.issue=5&rft.spage=718&rft.epage=723&rft.pages=718-723&rft.issn=1340-6868&rft.eissn=1880-4233&rft_id=info:doi/10.1007/s12282-015-0630-y&rft_dat=%3Cgale_proqu%3EA712277187%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1814676050&rft_id=info:pmid/26243043&rft_galeid=A712277187&rfr_iscdi=true |